At the World Health Summit in Berlin, OHE brought together senior leaders from across global health and finance to ask why prevention, despite strong returns and near-universal support, keeps losing out to treatment.
For fifty years, health policy has called for a shift towards prevention. The evidence of value is strong, and few disagree with the principle. Yet in health systems around the world, prevention budgets continue to be squeezed as spending on treatment grows.
On 12 October 2026, alongside the World Health Summit, OHE hosted a private dinner discussion with leaders from multilateral development banks, global health agencies, industry, investors, philanthropy and civil society. Held under the Chatham House Rule, the discussion explored three questions: where the money for prevention could come from, how prevention could be made investable, and what one change could make a difference within a year.
Organisations represented included Access to Medicine Foundation, Amazon Web Services, Asian Development Bank, Bayer, Bertelsmann Stiftung, Gavi, IFPMA, NCD Alliance, Regionalized Vaccine Manufacturing Collaborative, Syncona Investment Management and the World Bank.
A clear conclusion emerged: the barrier is not the evidence but how prevention is accounted for and paid for. Treasuries classify prevention as spending rather than investment, its benefits arrive later and often accrue to someone other than the payer, and the methods used to assess value were built for treatments rather than avoided harm. Participants saw these as solvable problems, pointing to practical levers in fiscal treatment, assessment methods and outcomes-based financing.
The synthesis note captures the main themes of the discussion without attribution.
OHE will take this work forward through the prevention stream of our Change Initiative. To find out more or to get involved, contact Charlotte Ashton, Director of External Affairs, at cashton@ohe.org.
Related
Financing Prevention: Unlocking Investment in a Healthier Future
The Financing Prevention programme is a collaborative research initiative led by OHE, designed to tackle the root causes of underinvestment in preventive health. Rather than asking whether prevention works, this programme focuses on how to fund it.